| Net Cash Provided by (Used in) Operating Activities |
$49,295 |
USD |
-1073% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$48,920 |
USD |
1249% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
480,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
124,054,600 |
shares |
2.6% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$375 |
USD |
35% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$688,800 |
USD |
1.8% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$688,800 |
USD |
1.8% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |